TREE NEWS update: Illumina said deliveries of its China-produced MiSeq i100 Series-CN sequencer will exceed 20 units by the end of this year, after the first batch built at its local manufacturing base was handed to customers. The product, launched in China in August, was showcased at a CIIE milestone event on November 6. Illumina said the locally made system meets global quality standards while offering supply and service closer to the Chinese market.
Illumina: China-made MiSeq i100 Series-CN deliveries to exceed 20 units by year-end
AI take
Local manufacturing is the real signal here: Illumina is rebuilding its China footprint around production and service proximity, not just product launches, which matters for a market where supply reliability has become a competitive issue. The stated delivery target is small in absolute terms, so the significance lies in proof of execution rather than scale. For China's genomics and clinical sequencing users, the question worth watching is whether local output and service depth keep pace with demand, and whether the quality-parity claim holds as volumes grow.
Generated by AI for reference only.
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
54m ago
Binance France to charge account fees from Nov 29, close all accounts by year-end
1h ago
Musk Denies Ever Criticizing Binance’s Market Dominance
1h ago
Binance’s He Yi: UIDs Are Unique, Local Fiat Platforms Don’t Share Accounts
1h ago
Bitget Opens Anthropic IPO Subscription via IPO Prime From $100
1h ago
CZ Warns of Windows Flaw Risk, Urges Users to Update OS
1h ago
Volvo Denies Airbag Recall Text Message Rumors